India  

Merck seeks FDA emergency use authorization for antiviral COVID-19 treatment molnupiravir

Video Credit: WXYZ Detroit - Duration: 02:56s - Published
Merck seeks FDA emergency use authorization for antiviral COVID-19 treatment molnupiravir

Merck seeks FDA emergency use authorization for antiviral COVID-19 treatment molnupiravir

Pharmaceutical giant Merck has applied for Emergency Use Authorization for its promising antiviral COVID-19 treatment.

If the FDA grants approval, it would be the first pill in the US to treat the coronavirus disease.


You Might Like


Related videos from verified sources

FDA issues emergency use authorization for Pfizer vaccine in children 5 to 11 [Video]

FDA issues emergency use authorization for Pfizer vaccine in children 5 to 11

FDA issues EUA for Pfizer vaccine in kids 5 to 11

Credit: WEWS NewsChannel5     Duration: 02:55Published
FDA panel unanimously votes to recommend Pfizer vaccine for kids as young as 5 [Video]

FDA panel unanimously votes to recommend Pfizer vaccine for kids as young as 5

On Tuesday, a key Food and Drug Administration (FDA) panel voted to formally recommend that children as young as 5 be authorized to receive Pfizer's COVID-19 vaccine under emergency use authorization.

Credit: 7News - The Denver Channel     Duration: 02:14Published
FDA panel votes to recommend Pfizer vaccine for kids as young as 5 [Video]

FDA panel votes to recommend Pfizer vaccine for kids as young as 5

On Tuesday, a key FDA advisory panel voted to formally recommend that children as young as 5 be authorized to receive Pfizer's COVID-19 vaccine under Emergency Use Authorization.

Credit: ABC Action News     Duration: 02:08Published